Loading people...
Ben Carter is an Investment Manager on the Life Sciences team at Deepbridge Capital, an investment management firm based in the United Kingdom. In this current capacity, he manages early-stage venture capital investments in innovative healthcare technology and biotechnology startups through the firm's tax-efficient Enterprise Investment Scheme and Seed Enterprise Investment Scheme fund portfolios. Prior to joining Deepbridge Capital, Carter served as the Chief Commercial Officer at Now Healthcare Group, a prominent telemedicine provider recognized for developing the Dr Now mobile application. He previously held the position of Commercial Director at Telmenow, an e-commerce platform specializing in healthcare equipment, and worked as the Managing Director of Touchpoint Service. Carter's professional background combines direct operational leadership in digital health startups with a current focus on directing venture funding toward growth-stage life sciences and medical technology enterprises.
Ben Carter serves as a dedicated investor at Deepbridge Capital, a prominent UK venture capital firm renowned for its strategic investments in innovative, high-growth potential businesses. In his role, Ben is instrumental in shaping Deepbridge's investment portfolio, focusing on identifying companies poised for significant expansion and providing the capital and strategic guidance necessary for their success.
Deepbridge Capital operates with a clear mission to support the UK's most promising enterprises, often leveraging Enterprise Investment Scheme (EIS) and Seed Enterprise Investment Scheme (SEIS) funds. Ben Carter's expertise is particularly valuable in navigating these complex investment landscapes, ensuring that Deepbridge's capital is deployed effectively to foster innovation and generate strong returns for investors.
Ben's investment focus areas align closely with Deepbridge Capital's core strengths: technology and life sciences. Within technology, he actively seeks out opportunities in areas such as advanced software, artificial intelligence, fintech, and digital transformation solutions that are disrupting traditional markets or creating new ones. In the life sciences sector, Ben's interests span biotechnology, medical technology, pharmaceuticals, and digital health innovations that promise to improve patient outcomes and advance healthcare.
His responsibilities extend beyond initial investment. Ben is deeply involved in the due diligence process, meticulously evaluating potential ventures for their market viability, management team strength, and scalability. Post-investment, he works closely with portfolio companies, offering strategic advice, connecting them with industry experts, and helping them overcome growth challenges. This hands-on approach underscores his commitment to not just funding, but actively building successful businesses.
While specific details of Ben Carter's career background prior to Deepbridge Capital are not publicly detailed, his contributions reflect a strong foundation in venture capital, finance, or a related industry, equipping him with the analytical rigor and market insight essential for his role. His work at Deepbridge Capital exemplifies a dedication to fostering the next generation of UK innovators, contributing significantly to the firm's reputation as a leading investor in the country's most dynamic sectors.
Ben Carter's strategic vision and commitment to supporting groundbreaking companies make him a vital part of the Deepbridge Capital team, driving forward investments that aim to deliver both financial returns and meaningful impact.
Ben Carter is an investor at Deepbridge Capital, a UK venture capital firm. He plays a crucial role in identifying and investing in high-growth potential companies, primarily in the technology and life sciences sectors.
Ben Carter primarily invests in growth-stage companies within the technology and life sciences sectors. This includes areas such as software, artificial intelligence, biotechnology, medical technology, and digital health, often through Deepbridge Capital's EIS and SEIS funds.
Ben Carter works as an investor at Deepbridge Capital. Deepbridge Capital is a UK-based venture capital firm known for its focus on EIS and SEIS investments across various innovative sectors.
